Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua D Woolley

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 9, 2025
Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trialEllen R Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, et al.
Nature Medicine|May 11, 2021
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 studyJennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, et al.
Focus (American Psychiatric Publishing)|July 5, 2023
MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 StudyJennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 9, 2025
Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trialEllen R Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, et al.
Nature Medicine|May 11, 2021
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 studyJennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, et al.
Focus (American Psychiatric Publishing)|July 5, 2023
MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 StudyJennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, et al.
Pageof 5